JANX - Janux Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JANX is currently covered by 5 analysts with an average price target of $69.72. This is a potential upside of $42.37 (154.92%) from yesterday's end of day stock price of $27.35.

Janux Therapeutics's activity chart (see below) currently has 35 price targets and 41 ratings on display. The stock rating distribution of JANX is 78.57% BUY and 21.43% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.52% with an average time for these price targets to be met of 270.71 days.

Highest price target for JANX is $200, Lowest price target is $36, average price target is $91.2.

Most recent stock forecast was given by BRADLEY CANINO from STIFEL on 10-Sep-2025. First documented stock forecast 06-Jul-2021.

Currently out of the existing stock ratings of JANX, 11 are a BUY (78.57%), 3 are a HOLD (21.43%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$45

$20.1 (80.72%)

$72

1 months 17 days ago
(10-Sep-2025)

0/5 (0%)

$20.69 (85.11%)

Hold

$36

$11.1 (44.58%)

$41

5 months 18 days ago
(09-May-2025)

3/5 (60%)

$10.44 (40.85%)

7

Buy

$70

$45.1 (181.12%)

$70

7 months 24 days ago
(03-Mar-2025)

10/12 (83.33%)

$38.17 (119.92%)

252

Buy

$200

$175.1 (703.21%)

$200

10 months 16 days ago
(11-Dec-2024)

1/7 (14.29%)

$136.55 (215.21%)

966

Buy

$105

$80.1 (321.69%)

$70

10 months 24 days ago
(03-Dec-2024)

0/2 (0%)

$45.14 (75.41%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JANX (Janux Therapeutics) average time for price targets to be met?

On average it took 270.71 days on average for the stock forecasts to be realized with a an average price target met ratio 47.52

Which analyst has the current highest performing score on JANX (Janux Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on JANX (Janux Therapeutics) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on JANX (Janux Therapeutics)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 0 price targets and 0 ratings on JANX

Which analyst is the currently most bullish on JANX (Janux Therapeutics)?

Josh Schimmer with highest potential upside - $175.1

Which analyst is the currently most reserved on JANX (Janux Therapeutics)?

George Farmer with lowest potential downside - $11.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?